# Seven Fleet Capital Management LP 13F Q2 2026: $606 million

Seven Fleet Capital Management LP reported $606 million in 13F securities across 96 positions for the quarter ended June 30, 2026, in a holdings report filed August 17, 2026. Its largest holding was CG Oncology Inc at $134 million, 22.1% of the reported value. Since Q1 2026 it opened 24 new positions and exited 43.

SpecStream is the live web data engine for teams and agents. It reads the SEC's Form 13F data sets each quarter, and this page is that reading, keyed on the manager's CIK and the security's CUSIP. Ask for the managers or the holdings you track, and each new 13F filing arrives in your sheet, CRM, Slack or agent as the SEC publishes it.

- Quarter: Q2 2026, the quarter ended June 30, 2026
- Reported value: $605,916,390
- Positions: 96
- Filed: August 17, 2026
- Report type: 13F holdings report
- CIK: 2092021
- Form 13F file number: 028-26709
- CRD number: 335203
- Business address: 960 San Clemente Way, Mountain View, CA 94043
- SEC filing: [0001013594-26-000921](https://www.sec.gov/Archives/edgar/data/2092021/000101359426000921/0001013594-26-000921-index.htm)

## Top 25 holdings by value

The largest of 96 positions by reported value at the end of the quarter ended June 30, 2026. Put and call options are marked in the class. Change is in shares or principal against the filing for the quarter ended March 31, 2026.

| Issuer | Class | Shares or principal | Value | Change since Q1 2026 |
| --- | --- | --- | --- | --- |
| [CG Oncology Inc](https://specstream.ai/data/institutional-holders/cg-oncology-inc-156944100) | COM | 1,886,236 | $134 million | +1,810,478 |
| [Tango Therapeutics Inc](https://specstream.ai/data/institutional-holders/tango-therapeutics-inc-87583x109) | COM | 3,228,144 | $95.7 million | +2,726,132 |
| [Revolution Medicines Inc](https://specstream.ai/data/institutional-holders/revolution-medicines-inc-76155x100) | COM | 242,029 | $45.3 million | +161,237 |
| [Pharvaris N V](https://specstream.ai/data/institutional-holders/pharvaris-n-v-n69605108) | COM | 774,501 | $26.8 million | +601,770 |
| [Liquidia Corporation](https://specstream.ai/data/institutional-holders/liquidia-corporation-53635d202) | COM NEW | 256,603 | $20.5 million | +68,727 |
| [Enliven Therapeutics Inc](https://specstream.ai/data/institutional-holders/enliven-therapeutics-inc-29337e102) | COM | 365,386 | $18.5 million | +201,356 |
| [Abivax SA](https://specstream.ai/data/institutional-holders/abivax-sa-00370m103) | SPONSORED ADS | 111,334 | $14.8 million | +68,282 |
| [Avalo Therapeutics Inc](https://specstream.ai/data/institutional-holders/avalo-therapeutics-inc-05338f306) | COM NEW | 770,765 | $14.2 million | +556,946 |
| [Mirum Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/mirum-pharmaceuticals-inc-604749101) | COM | 110,393 | $12.9 million | New |
| [Assembly Biosciences Inc](https://specstream.ai/data/institutional-holders/assembly-biosciences-inc-045396207) | COM NEW | 433,147 | $11.9 million | +377,000 |
| [Century Therapeutics Inc](https://specstream.ai/data/institutional-holders/century-therapeutics-inc-15673t100) | COM | 4,347,826 | $10.7 million | +1,400,000 |
| [Cytokinetics Inc](https://specstream.ai/data/institutional-holders/cytokinetics-inc-23282w605) | COM NEW | 118,240 | $10.1 million | +56,971 |
| [Taysha Gene Therapies Inc](https://specstream.ai/data/institutional-holders/taysha-gene-therapies-inc-877619106) | COM SHS | 1,504,400 | $9.9 million | +878,692 |
| [Veradermics Inc](https://specstream.ai/data/institutional-holders/veradermics-inc-922967104) | COMMON STOCK | 80,000 | $9.8 million | New |
| [Arrivent Biopharma Inc](https://specstream.ai/data/institutional-holders/arrivent-biopharma-inc-04272n102) | COM | 246,606 | $8.6 million | +196,354 |
| [Tarsus Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/tarsus-pharmaceuticals-inc-87650l103) | COM | 117,067 | $7.9 million | +97,267 |
| [Xencor Inc](https://specstream.ai/data/institutional-holders/xencor-inc-98401f105) | COM | 368,305 | $7.8 million | +288,305 |
| [Roivant Sciences LTD](https://specstream.ai/data/institutional-holders/roivant-sciences-ltd-g76279101) | SHS | 220,126 | $7.8 million | +91,958 |
| [Damora Therapeutics Inc](https://specstream.ai/data/institutional-holders/damora-therapeutics-inc-36322q206) | COM NEW | 284,430 | $7.4 million | +183,182 |
| [Axsome Therapeutics Inc.](https://specstream.ai/data/institutional-holders/axsome-therapeutics-inc-05464t104) | COM | 28,826 | $7.1 million | +14,771 |
| [Definium Therapeutics Inc](https://specstream.ai/data/institutional-holders/definium-therapeutics-inc-24477v105) | COM SHS | 148,647 | $7 million | +48,760 |
| [Dianthus Therapeutics Inc](https://specstream.ai/data/institutional-holders/dianthus-therapeutics-inc-252828108) | COM | 64,723 | $6.3 million | +10,465 |
| [Cogent Biosciences Inc](https://specstream.ai/data/institutional-holders/cogent-biosciences-inc-19240q201) | COM | 147,510 | $5.7 million | -1,889 |
| [Erasca Inc](https://specstream.ai/data/institutional-holders/erasca-inc-29479a108) | COM | 308,007 | $5.6 million | +85,539 |
| [Protagonist Therapeutics Inc](https://specstream.ai/data/institutional-holders/protagonist-therapeutics-inc-74366e102) | COM | 45,400 | $5.6 million | +41,400 |

## New positions in Q2 2026

24 positions not in the filing for the quarter ended March 31, 2026.

| Issuer | Class | Shares or principal | Value |
| --- | --- | --- | --- |
| [Mirum Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/mirum-pharmaceuticals-inc-604749101) | COM | 110,393 | $12.9 million |
| [Veradermics Inc](https://specstream.ai/data/institutional-holders/veradermics-inc-922967104) | COMMON STOCK | 80,000 | $9.8 million |
| [Editas Medicine Inc](https://specstream.ai/data/institutional-holders/editas-medicine-inc-28106w103) | COM | 1,330,500 | $4.3 million |
| [Sutro Biopharma Inc](https://specstream.ai/data/institutional-holders/sutro-biopharma-inc-869367201) | COM SHS | 159,118 | $3.8 million |
| [Ascendis Pharma A/S](https://specstream.ai/data/institutional-holders/ascendis-pharma-a-s-k08588103) | ORD SHS | 11,869 | $3.2 million |
| [Sagimet Biosciences Inc](https://specstream.ai/data/institutional-holders/sagimet-biosciences-inc-786700104) | COM SER A | 403,545 | $3.1 million |
| [Praxis Precision Medicines I](https://specstream.ai/data/institutional-holders/praxis-precision-medicines-i-74006w207) | COM NEW | 7,540 | $2.5 million |
| [Relmada Therapeutics Inc](https://specstream.ai/data/institutional-holders/relmada-therapeutics-inc-75955j402) | COM | 348,265 | $2.4 million |
| [Xenon Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/xenon-pharmaceuticals-inc-98420n105) | COM | 33,300 | $2.1 million |
| [Syndax Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/syndax-pharmaceuticals-inc-87164f105) | COM | 77,930 | $1.6 million |
| [Adlai Nortye LTD](https://specstream.ai/data/institutional-holders/adlai-nortye-ltd-00704r109) | SPONSORED ADS | 113,207 | $1.3 million |
| [Onkure Therapeutics Inc](https://specstream.ai/data/institutional-holders/onkure-therapeutics-inc-68277q105) | COM CL A | 240,963 | $1.1 million |
| [Summit Therapeutics Inc](https://specstream.ai/data/institutional-holders/summit-therapeutics-inc-86627t108) | COM | 73,300 | $1.1 million |
| [Engene Therapeutics Inc](https://specstream.ai/data/institutional-holders/engene-therapeutics-inc-29286x101) | COM | 411,065 | $711,142 |
| [Neurogene Inc](https://specstream.ai/data/institutional-holders/neurogene-inc-64135m105) | COM | 22,060 | $693,787 |
| [Ishares TR](https://specstream.ai/data/institutional-holders/ishares-tr-464288810) | U.S. MED DVC ETF | 13,800 | $681,858 |
| [Olema Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/olema-pharmaceuticals-inc-68062p106) | COM | 31,476 | $393,765 |
| [Cue Biopharma Inc](https://specstream.ai/data/institutional-holders/cue-biopharma-inc-22978p205) | COM | 10,702 | $337,755 |
| [MBX Biosciences Inc](https://specstream.ai/data/institutional-holders/mbx-biosciences-inc-55287l101) | COM | 6,000 | $331,200 |
| [Astrazeneca PLC](https://specstream.ai/data/institutional-holders/astrazeneca-plc-g0593m107) | ORD | 1,400 | $265,468 |
| [Stoke Therapeutics Inc](https://specstream.ai/data/institutional-holders/stoke-therapeutics-inc-86150r107) | COM | 7,745 | $255,353 |
| [Viking Therapeutics Inc](https://specstream.ai/data/institutional-holders/viking-therapeutics-inc-92686j106) | COM | 7,404 | $251,884 |
| [Wave Life Sciences LTD](https://specstream.ai/data/institutional-holders/wave-life-sciences-ltd-y95308105) | SHS | 19,048 | $99,812 |
| [Uniqure NV](https://specstream.ai/data/institutional-holders/uniqure-nv-n90064101) | SHS | 338 | $15,254 |

## Positions exited in Q2 2026

43 positions in the filing for the quarter ended March 31, 2026 and not in this one, with the shares and value reported then. The 25 largest are shown.

| Issuer | Class | Shares or principal | Value |
| --- | --- | --- | --- |
| CG Oncology Inc | COM | 1,439,393 | $97.4 million |
| [Tyra Biosciences Inc](https://specstream.ai/data/institutional-holders/tyra-biosciences-inc-90240b106) | COM | 195,685 | $7.5 million |
| Tango Therapeutics Inc | COM | 300,648 | $6.3 million |
| Avalo Therapeutics Inc | COM NEW | 360,064 | $5.4 million |
| Minerva Neurosciences Inc | COM NEW | 889,254 | $5.4 million |
| Pharvaris N V | COM | 143,966 | $4.1 million |
| Soleno Therapeutics Inc | COM | 115,770 | $3.9 million |
| Enliven Therapeutics Inc | COM | 95,253 | $3.7 million |
| Cytomx Therapeutics Inc. | COM | 714,000 | $3.4 million |
| Century Therapeutics Inc | COM | 1,400,000 | $3.2 million |
| Ascendis Pharma A/S | SPONSORED ADR | 12,179 | $2.8 million |
| Kalvista Pharmaceuticals Inc | COM | 128,487 | $2.6 million |
| Compass Therapeutics Inc | COM | 423,566 | $2.2 million |
| Dianthus Therapeutics Inc | COM | 26,551 | $2.2 million |
| Eupraxia Pharmaceuticals Inc | COM | 276,000 | $2 million |
| [Mineralys Therapeutics Inc](https://specstream.ai/data/institutional-holders/mineralys-therapeutics-inc-603170101) | COM | 69,571 | $1.9 million |
| Soleno Therapeutics Inc | COM | 54,000 | $1.8 million |
| Sab Biotherapeutics Inc | COM NEW | 400,000 | $1.5 million |
| Vaxcyte Inc | COM | 20,000 | $1.2 million |
| [Replimune Group Inc](https://specstream.ai/data/institutional-holders/replimune-group-inc-76029n106) | COM | 120,400 | $921,060 |
| [Maze Therapeutics Inc](https://specstream.ai/data/institutional-holders/maze-therapeutics-inc-578784100) | COM | 30,707 | $916,604 |
| [Climb Bio Inc](https://specstream.ai/data/institutional-holders/climb-bio-inc-28658r106) | COM | 130,654 | $894,980 |
| [Compass Pathways PLC](https://specstream.ai/data/institutional-holders/compass-pathways-plc-20451w101) | SPONSORED ADS | 158,021 | $873,856 |
| [Denali Therapeutics Inc](https://specstream.ai/data/institutional-holders/denali-therapeutics-inc-24823r105) | COM | 35,286 | $677,491 |
| [United Therapeutics Corp Del](https://specstream.ai/data/institutional-holders/united-therapeutics-corp-del-91307c102) | COM | 1,128 | $668,881 |

## Also on SpecStream

- [Seven Fleet Capital Management LP Form 13F filing on EDGAR](https://www.sec.gov/Archives/edgar/data/2092021/000101359426000921/0001013594-26-000921-index.htm)
- [Largest 13F filers in California](https://specstream.ai/data/institutional-holdings/state/california)
- [Largest institutional managers by 13F value](https://specstream.ai/data/institutional-holdings)
- [Most widely held securities in 13F filings](https://specstream.ai/data/institutional-holders)

Source: [the SEC's Form 13F data sets](https://www.sec.gov/data-research/sec-markets-data/form-13f-data-sets). Public data published by the US Securities and Exchange Commission (US government work). Managers report these holdings themselves in Form 13F, and the SEC does not check or guarantee them. Form 13F lists long positions in US listed equities, some options and convertible notes held at the end of the quarter, and leaves out short positions, cash, most bonds and holdings below the reporting threshold. Values are market values in US dollars as the manager filed them. A manager can ask the SEC to keep some positions confidential for a time. This page uses SEC data and is not endorsed or certified by the SEC.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in Mountain View, California

- [Engineering firms in Mountain View, California](https://specstream.ai/data/businesses/engineering-firms/mountain-view-california-united-states)
- [Insurance agencies in Mountain View, California](https://specstream.ai/data/businesses/insurance-agencies/mountain-view-california-united-states)
- [Software development companies in Mountain View, California](https://specstream.ai/data/businesses/software-development-companies/mountain-view-california-united-states)
- [Dental clinics in Mountain View, California](https://specstream.ai/data/businesses/dental-clinics/mountain-view-california-united-states)
- [Hotels in Mountain View, California](https://specstream.ai/data/businesses/hotels/mountain-view-california-united-states)
- [Preschools in Mountain View, California](https://specstream.ai/data/businesses/preschools/mountain-view-california-united-states)
